Please assess the completion status of the following clinical trial:

Trial Title: Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* diabetes type 2~* HbA1c 8% or higher~* age 25 to 65~Exclusion Criteria:~* alteration in insulin sensitivity such as major surgery, infection, renal failure (Glomerular Filtration Rate \< 50),~* glucocorticoid treatment,~* recent (within 2 weeks) serious hypoglycemic episode (requires assistance of another),~* simultaneous participating in another clinical study,~* using any type of insulin,~* sight or hearing impaired,~* active proliferative retinopathy or maculopathy require treatment within 6 months prior to screening,~* breast feeding,~* pregnancy or nursing of the intention of becoming pregnant or~* not using adequate contraceptive measures.

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- BIAsp 30 (Type: EXPERIMENTAL): patients receiving variable doses of Insulin BIAsp 30.start with 0.2 to 0.6unit per kg
- NPH/Reg (Type: ACTIVE_COMPARATOR): patients receiving Variable doses Of Insulin NPH Start with 0.2 to 0.6 unit per kg

Based on this trial design, predict the completion outcome and termination type (if applicable).